{"protocolSection":{"identificationModule":{"nctId":"NCT06156059","orgStudyIdInfo":{"id":"Mel-ICU"},"organization":{"fullName":"Hospital San Carlos, Madrid","class":"OTHER"},"briefTitle":"Oral Bedtime Melatonin in Critically Ill Patients","officialTitle":"Oral Bedtime Melatonin in Critically Ill Patients","acronym":"Mel-ICU"},"statusModule":{"statusVerifiedDate":"2023-11","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-02-01","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2026-02-01","type":"ESTIMATED"},"completionDateStruct":{"date":"2026-04-01","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-11-26","studyFirstSubmitQcDate":"2023-11-26","studyFirstPostDateStruct":{"date":"2023-12-05","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-11-26","lastUpdatePostDateStruct":{"date":"2023-12-05","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Miguel Sanchez Garcia","investigatorTitle":"Director Critical Care Department","investigatorAffiliation":"Hospital San Carlos, Madrid"},"leadSponsor":{"name":"Hospital San Carlos, Madrid","class":"OTHER"},"collaborators":[{"name":"Universidad Complutense de Madrid","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Oxidative stress is one of the main mechanisms causing harm in severe infection with septic shock, ischemia-reperfusion injury in resuscitated cardiac arrest and ischemic and hemorrhagic stroke.\n\nMelatonin is a potent scavenger of the mediators of oxidative stress, oxygen and nitrogen-reactive species, which directly injure cell structures like walls and DNA and thus cause organ dysfunction.\n\nIn a previous study we have observed that high-dose oral bedtime melatonin (OBM) is associated with improved organ function in severe Covid-19 patients","detailedDescription":"We intend to perform a double-blind randomized, adaptive trial in the 4 indications mentioned above giving 100 mg of OBM or placebo.\n\nInterim analyses with pre-specified stopping rules will be perform in each sub-study for specific outcome variables collected at scheduled timelines.\n\nComparative organ dysfunction score (Sequential Organ Failure Evaluation-SOFA) will be done at baseline, 7, 14, and 30 days and mortality evaluated at 30 and 90 days.\n\nFor the 3 study groups enrolling stroke and resuscitated cardiac arrest patients, the modified Rankin score and the CVC (Glasgow) at 30 and 90 days will be compared."},"conditionsModule":{"conditions":["Septic Shock","Stroke Hemorrhagic","Strokes Thrombotic","Cardiac Arrest"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","interventionModelDescription":"double blind randomized","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","maskingDescription":"Indistinguishable oral suspension or capsule","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":160,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Septic Shock Standard of Care (SOC)","type":"PLACEBO_COMPARATOR","description":"Placebo suspension and capsules","interventionNames":["Drug: Placebo suspension or capsule"]},{"label":"Septic shock Oral Bedtime Melatonin (OBM)","type":"ACTIVE_COMPARATOR","description":"100 mg suspension or in capsules OBM","interventionNames":["Drug: Oral Bedtime Melatonin"]},{"label":"Resuscitated Cardiorespiratory Arrest SOC","type":"PLACEBO_COMPARATOR","description":"Placebo suspension and capsules","interventionNames":["Drug: Placebo suspension or capsule"]},{"label":"Resuscitated Cardiorespiratory Arrest OBM","type":"ACTIVE_COMPARATOR","description":"100 mg suspension or in capsules OBM","interventionNames":["Drug: Oral Bedtime Melatonin"]},{"label":"Ischemic Stroke (SOC)","type":"PLACEBO_COMPARATOR","description":"Placebo suspension and capsules","interventionNames":["Drug: Placebo suspension or capsule"]},{"label":"Ischemic stroke (OBM)","type":"ACTIVE_COMPARATOR","description":"100 mg suspension or in capsules OBM","interventionNames":["Drug: Oral Bedtime Melatonin"]},{"label":"Hemorraghic stroke (SOC)","type":"PLACEBO_COMPARATOR","description":"Placebo suspension and capsules","interventionNames":["Drug: Placebo suspension or capsule"]},{"label":"Hemorrhagic stroke (OBM)","type":"ACTIVE_COMPARATOR","description":"100 mg suspension or in capsules OBM","interventionNames":["Drug: Oral Bedtime Melatonin"]}],"interventions":[{"type":"DRUG","name":"Oral Bedtime Melatonin","description":"100 mg oral suspension or capsule given at bedtime","armGroupLabels":["Hemorrhagic stroke (OBM)","Ischemic stroke (OBM)","Resuscitated Cardiorespiratory Arrest OBM","Septic shock Oral Bedtime Melatonin (OBM)"],"otherNames":["Oral melatonin"]},{"type":"DRUG","name":"Placebo suspension or capsule","description":"Indistinguishable suspension or capsule","armGroupLabels":["Hemorraghic stroke (SOC)","Ischemic Stroke (SOC)","Resuscitated Cardiorespiratory Arrest SOC","Septic Shock Standard of Care (SOC)"],"otherNames":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Mortality at 90 days","description":"All-cause mortality","timeFrame":"Inclusion to 90 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* ICU stay \\>5 days\n\nExclusion Criteria:\n\n* ominous prognosis","healthyVolunteers":false,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083302","term":"Hemorrhagic Stroke"},{"id":"D000083244","term":"Thrombotic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000083242","term":"Ischemic Stroke"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M18700","name":"Critical Illness","relevance":"LOW"},{"id":"M15270","name":"Shock, Septic","relevance":"LOW"},{"id":"M9101","name":"Heart Arrest","relevance":"LOW"},{"id":"M15267","name":"Shock","relevance":"LOW"},{"id":"M2405","name":"Hemorrhagic Stroke","asFound":"Stroke Hemorrhagic","relevance":"HIGH"},{"id":"M2402","name":"Thrombotic Stroke","asFound":"Strokes Thrombotic","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC01","name":"Infections"}]},"interventionBrowseModule":{"meshes":[{"id":"D000008550","term":"Melatonin"}],"ancestors":[{"id":"D000000975","term":"Antioxidants"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000020011","term":"Protective Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000002492","term":"Central Nervous System Depressants"}],"browseLeaves":[{"id":"M11223","name":"Melatonin","asFound":"Ketamine","relevance":"HIGH"},{"id":"M3982","name":"Antioxidants","relevance":"LOW"},{"id":"M21559","name":"Protective Agents","relevance":"LOW"},{"id":"T410","name":"Melatonin","asFound":"Ketamine","relevance":"HIGH"}],"browseBranches":[{"abbrev":"CNSDep","name":"Central Nervous System Depressants"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Ot","name":"Other Dietary Supplements"}]}},"hasResults":false}